SUN PHARMACEUTICAL INDUSTRIES
Back to Cashflow Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-1,437 Cr | ₹860 Cr | ₹4,735 Cr | ₹-608 Cr | ₹-1,934 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-1,437 Cr |
| Mar2025 | ₹860 Cr |
| Mar2024 | ₹4,735 Cr |
| Mar2023 | ₹-608 Cr |
| Mar2022 | ₹-1,934 Cr |
How is Net Cash Inflow / Outflow of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-1,437 Cr | Negative | |
| Mar2025 | ₹860 Cr | -81.83 | |
| Mar2024 | ₹4,735 Cr | Positive | |
| Mar2023 | ₹-608 Cr | Negative | |
| Mar2022 | ₹-1,934 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,956.2 Cr | 2.7% | 1.4% | 4.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹269,451.0 Cr | 4.5% | 6.3% | 50.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,456.0 Cr | 1.8% | -1.3% | 31.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,664.0 Cr | 0.8% | 12.5% | 14.1% | Stock Analytics | |
| CIPLA | ₹113,246.0 Cr | 1.6% | 4.4% | -9.1% | Stock Analytics | |
| MANKIND PHARMA | ₹103,881.0 Cr | 1.1% | 1.2% | 3.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 2.7% |
1.4% |
4.3% |
| SENSEX | 7% |
9.6% |
-6.7% |
You may also like the below Video Courses